Because the IGF-1R, Src, and AXL signaling pathways have been implicated in tumor growth and metastasis 22, 23, 54, we compared the effects of single treatment of LL6 and linsitinib (L), dasatinib (D), and bemcentinib (B) combination (LDB) on proliferation and metastatic activities of NSCLC cells in vitro. Here, IGF1R is linked to non-small cell lung carcinoma.